Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of September:

• Wells Fargo 2023 Healthcare Conference on Thursday, September 7, 2023 at 8:45 am (EDT)
• Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 at 11:20 am (EDT)
• Bank of America 2023 Global Healthcare Conference on Thursday, September 14, 2023 at 8:15 am (BST)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230822167395/en/

Media
Catalina Loveman
+1 302 498 6171
[email protected]

Investors
Gregory Shertzer
+1 302 274 4779
[email protected]

Source: Incyte

You May Also Be Interested In

• Broadcom secures $63 billion from banks to finance AI compute sales to Anthropic
• After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
• AimedBio and Boehringer Ingelheim initiate Phase I study of antibody-drug conjugate BI 4060107